baCta
Paris-based industrial biotech startup founded in 2024 that uses AI-powered precision fermentation to engineer yeast as molecular factories producing astaxanthin and other high-value ingredients for cosmetics, human nutrition, and animal nutrition markets.
- Company typePrivate
- Founded2024
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
baCta firmographics
Firmographics- Name
- baCta
- Legal name
- baCta
- Website
- https://bacta.life
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Paris-based industrial biotech startup founded in 2024 that uses AI-powered precision fermentation to engineer yeast as molecular factories producing astaxanthin and other high-value ingredients for cosmetics, human nutrition, and animal nutrition markets.
- Ownership category
- akta.pro rank
baCta industry classification
Industry- Product category
- Industrial Biotechnology / Bio-based Ingredients
- akta.pro primary industry
- Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)
- akta.pro secondary industries
- Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts) (CRADAOAI), Yeast Products & Fermentation Metabolites (Yeast Culture, MOS/β-Glucans) (AFADALAM)
Keywords
Where baCta is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
baCta business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Industrial Ingredient Sales: Sale of bio-based industrial ingredients (starting with astaxanthin) to cosmetics, human nutrition, and animal nutrition markets through B2B commercial partnerships
- Platform Licensing: Potential licensing of baCtaForge platform technology to industrial manufacturers for customized bioproduction applications
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
baCta product offering
Product offeringCore offering
baCta develops and operates baCtaForge, an AI-powered bioproduction platform that uses synthetic biology, robotics, and generative AI to engineer microorganisms as programmable molecular factories for sustainable industrial ingredient manufacturing. The company produces high-value bio-based ingredients via precision fermentation, with Astaxanthin as its first commercial product targeting cosmetics, human nutrition, and animal nutrition markets. The platform combines a Genome-to-Factory AI model, Precision Biofoundry automation, and full-stack bioproduction for end-to-end strain engineering and fermentation.
Product overview
baCta is a Paris-based industrial biotech startup founded in 2024 that has developed baCtaForge, an AI-powered bioproduction platform leveraging synthetic biology, robotics, and generative AI. The platform uses precision fermentation to engineer microorganisms as programmable molecular factories for sustainable production of high-value molecules. The platform consists of three integrated pillars: a Genome-to-Factory AI model that achieves predictive throughput for strain optimization, a Precision Biofoundry combining wet-lab automation with AI for strain engineering, and full-stack bioproduction capabilities for fermentation and downstream processing. The company's first commercial product is Astaxanthin, a high-value antioxidant produced via yeast fermentation, marketed in multiple high-performance forms for cosmetics, human nutrition, and animal nutrition markets.
Differentiator
Problem solved
Functional benefit
Brands
- baCtaForge: AI-powered bioproduction platform combining Genome-to-factory AI model, Precision Biofoundry, and full stack bioproduction for strain engineering and industrial fermentation.
Products and services
- baCtaForge Platform AI-powered bioproduction platform that integrates synthetic biology, robotics, and generative AI to engineer microorganisms as programmable molecular factories for sustainable industrial ingredient manufacturing, structured around three pillars: Genome-to-Factory AI model, Precision Biofoundry, and full-stack bioproduction.
- Astaxanthin High-value antioxidant compound produced via AI-optimized yeast fermentation as baCta's first commercial product, marketed to cosmetics, human nutrition, and animal nutrition markets with transparent traceability.
- Cosmetic Ingredients High-performance bio-based ingredient forms derived from baCtaForge-produced compounds, available in multiple forms with transparent traceability for cosmetics and personal care brands.
- Nutrition Ingredients High-performance bio-based ingredient forms derived from baCtaForge-produced compounds, available in multiple forms with transparent traceability for human nutrition and nutraceutical applications.
Quantifiable outcome
- Cell density over 100g/L versus under 5g/L for traditional algae methods
- +2 more outcomes
Companies that use baCta
Customer profileSegments3 records
Ideal customer profiles3 records
baCta technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
baCta partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- French Industrial ManufacturercoreStrategic partnership with a French industrial manufacturer to access production infrastructure for pilot and commercial-scale validation. Company is in advanced discussions with this partner for scale-up operations.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
baCta competitors and assessment
Company assessmentDirect peers
- Conagen: US-based precision fermentation company producing high-value ingredients including astaxanthin via engineered microorganisms. Closest direct comparable to baCta in technology stack (synthetic biology + fermentation), target molecule (astaxanthin), and B2B ingredient commercialization model.
- Manus Bio: Precision fermentation startup that engineers microorganisms to produce high-value specialty ingredients for flavors, fragrances, cosmetics, and nutrition. Directly comparable to baCta's technology approach (engineered microbial hosts, fermentation scale-up, B2B ingredient sales to CPG customers).
- Algalif: Iceland-based producer of natural astaxanthin from microalgae for nutraceuticals, cosmetics, and animal feed. Direct competitor in the same end markets with the same target molecule, though using extraction-based algae cultivation rather than yeast fermentation.
Broad incumbents
- dsm-firmenich: Global nutrition and ingredients conglomerate that produces and sells natural astaxanthin (e.g., PARRY/AstaPure brands) plus a broad portfolio of vitamins, carotenoids, and specialty ingredients. Direct incumbent competitor in baCta's target end markets (animal nutrition, nutrition, personal care).
- BASF: Global chemicals giant that produces synthetic astaxanthin (Lucantin) for animal feed and aquaculture, plus a broad portfolio of feed additives and nutrition ingredients. Represents the price benchmark that baCta's fermentation route must beat to gain share in animal nutrition.
- Ginkgo Bioworks: US-listed synthetic biology platform company that programs microorganisms for ingredient and industrial biotech applications across multiple end markets. Comparable to baCta in technology approach (AI + synbio + foundry automation) but operates as a broad horizontal platform with significantly more capital and scale.
- Kemin Industries: Private global ingredient manufacturer supplying antioxidants, pigments, and feed additives for animal nutrition, pet food, and human nutrition. Comparable to baCta as an established B2B ingredient supplier in the same target verticals, particularly animal nutrition.
Emerging players
- Bota Bio: Early-stage precision fermentation company developing microbial bioproduction for nutrition, personal care, and flavors & fragrances. Closely comparable to baCta in stage, technology stack (engineered microbial hosts + fermentation), and target B2B end markets.
- LanzaTech: US-listed carbon capture company using gas fermentation (engineered acetogens) to produce specialty chemicals, fuels, and ingredients from industrial off-gases. Comparable to baCta in core technology (precision fermentation of engineered microbes) and B2B ingredient commercialization, with overlapping end markets in cosmetics and nutrition.
- Solar Foods: Finnish precision fermentation company producing food ingredients (Solein protein) from CO2 and electricity using engineered microorganisms. Comparable to baCta in technology approach (precision fermentation of engineered microbes for B2B ingredient markets) and in pursuing novel food regulatory pathways.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
baCta social profiles
Digital presencebaCta financial estimates
Financial estimateRevenue estimate
Valuation estimate
baCta leadership team
Management profileNumber of profiles
Profiles3 records
baCta funding detail
Funding detailFunding overview
Funding rounds2 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
baCta M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about baCta
What does baCta do?
baCta develops and operates baCtaForge, an AI-powered bioproduction platform that uses synthetic biology, robotics, and generative AI to engineer microorganisms as programmable molecular factories for sustainable industrial ingredient manufacturing. The company produces high-value bio-based ingredients via precision fermentation, with Astaxanthin as its first commercial product targeting cosmetics, human nutrition, and animal nutrition markets. The platform combines a Genome-to-Factory AI model, Precision Biofoundry automation, and full-stack bioproduction for end-to-end strain engineering and fermentation.
Is baCta a public or private company?
baCta is a private company. It is classified as venture growth investor backed and is currently operating.
When was baCta founded?
baCta was founded in 2024. It employs 1 to 10 people.
Where is baCta based?
baCta is headquartered in Paris, France, in the Europe region.
How does baCta make money?
Two revenue lines are on record. Industrial Ingredient Sales are the primary driver. The others are platform Licensing.
Who are baCta's main competitors?
Direct peers on record are Conagen, Manus Bio and Algalif. Broad incumbents are dsm-firmenich, BASF, Ginkgo Bioworks and Kemin Industries. Emerging players are Bota Bio, LanzaTech and Solar Foods.
Does baCta have an API?
No public API is recorded for baCta.
What industry is baCta in?
baCta's product category is Industrial Biotechnology / Bio-based Ingredients. Its primary akta.pro industry code is AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing, with a secondary code of CRADAOAI, Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts).